# Jamieson Wellness Inc. (JWEL.TO) fundamentals

Data as of 2026-09-08. TSX, Canada. Sector: Consumer Defensive / Food & Staples Retailing. Price C$45.43, market value C$1.9 billion.

## Valuation
- **P/E (trailing): 24.8×** (5-yr avg 26.6×, 3-yr avg 26.2×). Jamieson Wellness Inc. trades at 24.8× trailing earnings, close to its own five-year average of 26.6×. The Consumer Defensive median in the September 2026 study was 20.1×. Forward P/E is 18.4×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.89**. A PEG of 0.89 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 2.1×**. Each dollar of revenue is priced at 2.1×.
- **Price / book: 3.7×**. The shares trade at 3.7× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 15.0×**. Enterprise value is 15.0× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 1.2%** (5-yr avg 2.8%). Free cash flow equals 1.2% of the market value, below its five-year average of 2.8%, so the shares are pricier on cash than usual.
- **Earnings yield: 4.0%**. The inverse of the P/E: 4.0% of the price is earned each year.

## Profitability
- **Gross margin: 41.9%**. Jamieson Wellness Inc. keeps 41.9% of revenue after the direct cost of what it sells.
- **Operating margin: 14.8%**. 14.8% of revenue is left after running the business.
- **Net margin: 7.6%**. 7.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 12.9%**. 12.9% on shareholders' equity is solid.
- **Return on invested capital: 10.5%**. Return on all capital, debt included, is 10.5%.
- **Return on assets: 6.5%**. Each dollar of assets produces 6.5% of profit.

## Growth
- **Revenue growth (1 yr): 12.0%** (3-yr 14.5%/yr, 5-yr 15.3%/yr). Revenue grew 12.0% over the last year, against 15.3% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 20.7%** (3-yr 5.3%/yr, 5-yr 7.6%/yr). Earnings per share rose 20.7%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 24.7%/yr**. Free cash flow has compounded at 24.7% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.97**. Debt is 0.97 times equity, moderate leverage.
- **Net debt / EBITDA: 2.8×**. It would take 2.8 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 5.6×**. Operating profit covers interest 5.6× over, a safe margin.
- **Current ratio: 2.59** (quick 1.43). Current assets cover the next year's liabilities 2.59 times.
- **Altman Z-score: 3.47**. A Z-score of 3.47 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 2.20%** (C$1.00 per share, trailing). Jamieson Wellness Inc. yields 2.20%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 60%** (168% of free cash flow). 60% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 9**. 9 straight years of increases.
- **Dividend growth (5 yr): 13.4%/yr** (1-yr 10.0%). The dividend has compounded at 13.4% a year over five years, doubling roughly every 5 years at that pace.

## Analyst view
- **Analyst consensus: hold** (7 analysts). 7 analysts cover Jamieson Wellness Inc.; the consensus is hold, with an average price target of C$46.21 (+2% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 25.2%** (YTD 36.8%, 3-mo 27.9%). The shares are up 25.2% over twelve months including dividends.
- **From 52-week high: -1.0%** (39.6% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 66**. An RSI of 66 is neutral.
- **Beta (1 yr): 0.38** (volatility 23%). Beta of 0.38 against the S&P/TSX Composite: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=JWEL.TO · Page: https://foliofundamentals.com/stocks/jwel.to

Not investment advice.